STOCK TITAN

Nebraska Medicine and Palantir Announce Pioneering Partnership to Use AI Technology to Advance Healthcare

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
partnership AI

Palantir Technologies Inc. (NYSE: PLTR) and Nebraska Medicine have announced a multi-year, multi-million-dollar contract for Palantir's Artificial Intelligence Platform (AIP) to advance healthcare innovation. In less than a year, Nebraska Medicine has implemented over ten AIP applications, resulting in significant improvements:

+2000% increase in Discharge Lounge utilization
• Average one-hour reduction in discharge time
1,200+ AI-powered appeal letters sent to payors in under 3 months

The partnership, which began in January 2024, has led to rapid advancements in patient throughput, claims reimbursements, and patient care monitoring. Nebraska Medicine is using AIP for various purposes, including predicting OR and PACU bed necessity, managing supply chains, and recommending staff movements.

Palantir Technologies Inc. (NYSE: PLTR) e Nebraska Medicine hanno annunciato un contratto pluriennale del valore di milioni di dollari per la piattaforma di intelligenza artificiale di Palantir (AIP) al fine di promuovere l'innovazione nella sanità. In meno di un anno, Nebraska Medicine ha implementato oltre dieci applicazioni AIP, portando a miglioramenti significativi:

Aumento del 2000% nell'utilizzo della lounge di dimissione
• Riduzione media di un'ora nel tempo di dimissione
• Inviati oltre 1.200 lettere di ricorso alimentate da AI ai pagatori in meno di 3 mesi

La collaborazione, iniziata a gennaio 2024, ha portato a rapidi progressi nel trattamento dei pazienti, nei rimborsi delle richieste e nel monitoraggio dell'assistenza ai pazienti. Nebraska Medicine sta utilizzando AIP per vari scopi, tra cui la previsione della necessità di letti in sala operatoria e PACU, la gestione delle catene di approvvigionamento e il consiglio sui movimenti del personale.

Palantir Technologies Inc. (NYSE: PLTR) y Nebraska Medicine han anunciado un contrato de varios años y múltiples millones de dólares para la Plataforma de Inteligencia Artificial de Palantir (AIP) con el fin de avanzar en la innovación sanitaria. En menos de un año, Nebraska Medicine ha implementado más de diez aplicaciones de AIP, lo que ha resultado en mejoras significativas:

Aumento del 2000% en la utilización del salón de alta
• Reducción promedio de una hora en el tiempo de alta
• Enviadas más de 1,200 cartas de apelación impulsadas por IA a los pagadores en menos de 3 meses

La asociación, que comenzó en enero de 2024, ha llevado a avances rápidos en el flujo de pacientes, reembolsos de reclamaciones y monitoreo de la atención al paciente. Nebraska Medicine está utilizando AIP para varios propósitos, incluyendo la predicción de la necesidad de camas en quirófano y PACU, la gestión de cadenas de suministro y la recomendación de movimientos de personal.

팔란티어 테크놀로지스 Inc. (NYSE: PLTR)와 네브래스카 메디신이 팔란티어의 인공지능 플랫폼(AIP)을 통해 의료 혁신을 촉진하기 위한 수년간의 다년 계약을 발표했습니다. 하나의 해가 되기 전, 네브래스카 메디신은 10개 이상의 AIP 애플리케이션을 구현하였으며, 이는 상당한 개선을 가져왔습니다:

2000% 증가한 퇴원 라운지 이용률
• 퇴원 시간의 1시간 감소
1,200개 이상의 AI 기반 항의서를 3개월도 안 되어 보험사에 발송

2024년 1월에 시작된 파트너십은 환자 처리, 청구 재정의 및 환자 치료 모니터링의 빠른 발전으로 이어졌습니다. 네브래스카 메디신은 AIP를 다양한 목적으로 사용하고 있으며, 여기에는 수술실 및 회복실(PACU) 침대 필요 예측, 공급망 관리 및 직원 이동 권장 등이 포함됩니다.

Palantir Technologies Inc. (NYSE: PLTR) et Nebraska Medicine ont annoncé un contrat pluriannuel de plusieurs millions de dollars pour la plateforme d'intelligence artificielle de Palantir (AIP) afin d'avancer l'innovation en santé. En moins d'un an, Nebraska Medicine a mis en œuvre plus de dix applications AIP, entraînant des améliorations significatives :

+2000% d'augmentation de l'utilisation du salon de sortie
• Réduction moyenne de une heure du temps de sortie
• Plus de 1 200 lettres d'appel alimentées par IA envoyées aux payeurs en moins de 3 mois

Le partenariat, qui a débuté en janvier 2024, a conduit à des avancées rapides dans le traitement des patients, les remboursements des demandes et la surveillance des soins aux patients. Nebraska Medicine utilise AIP à diverses fins, y compris la prévision des besoins en lits de salle d'opération et PACU, la gestion des chaînes d'approvisionnement et la recommandation des mouvements de personnel.

Palantir Technologies Inc. (NYSE: PLTR) und Nebraska Medicine haben einen mehrjährigen Vertrag im Wert von mehreren Millionen Dollar für die Künstliche Intelligenz-Plattform (AIP) von Palantir angekündigt, um Innovationen im Gesundheitswesen voranzutreiben. In weniger als einem Jahr hat Nebraska Medicine über zehn AIP-Anwendungen implementiert, was zu signifikanten Verbesserungen geführt hat:

+2000% Anstieg der Nutzung des Entlassungsraums
• Durchschnittliche eine Stunde Einsparung bei der Entlassungszeit
Über 1.200 KI-gesteuerte Widerspruchsschreiben in weniger als 3 Monaten an die Kostenträger gesendet

Die Partnerschaft, die im Januar 2024 begann, führte zu schnellen Fortschritten bei der Patientenabwicklung, den Anspruchszahlungen und der Patientenüberwachung. Nebraska Medicine nutzt AIP für verschiedene Zwecke, darunter die Vorhersage des Bedarfs an OP- und PACU-Betten, das Management von Lieferketten und die Empfehlung von Personalbewegungen.

Positive
  • Multi-year, multi-million-dollar contract secured with Nebraska Medicine
  • +2000% increase in Discharge Lounge utilization, freeing up beds earlier
  • Average one-hour reduction in time from discharge order to patient discharge
  • 1,200+ AI-powered appeal letters sent to payors in less than 3 months
  • Rapid implementation of over ten AIP applications in less than a year
  • Fastest time to enterprise commitment for Palantir in health system partnerships
Negative
  • None.

Insights

Nebraska Medicine's partnership with Palantir represents a significant leap in healthcare AI adoption. The rapid implementation of over ten AIP applications in less than a year demonstrates exceptional agility in the typically slow-moving healthcare sector. Key achievements include:

  • A staggering 2000% increase in Discharge Lounge utilization
  • Average reduction of one hour in patient discharge time
  • 1,200+ AI-powered appeal letters sent to payors in under 3 months

These outcomes suggest potential for substantial operational efficiencies and cost savings. However, the true test will be in long-term patient outcomes and financial performance. Investors should monitor for sustained improvements and any regulatory challenges that may arise from AI implementation in healthcare.

This partnership marks a strategic move for Palantir, expanding its footprint in the lucrative healthcare AI market. The multi-year, multi-million-dollar contract with a $2.5 billion health system like Nebraska Medicine could serve as a powerful case study for Palantir, potentially attracting more healthcare clients. The rapid adoption and implementation speed (6 weeks to production, 90 minutes for some workflows) is particularly noteworthy, as it could significantly reduce sales cycles and implementation costs for Palantir. However, investors should be cautious about extrapolating these results across the entire healthcare sector, as Nebraska Medicine seems to be an exceptionally innovative outlier.

The operational improvements reported are impressive and address critical pain points in hospital management. The 2000% increase in Discharge Lounge utilization and one-hour reduction in discharge time can significantly impact patient throughput and satisfaction. The AI-powered appeals process could potentially recover millions in denied claims, a major issue for many hospitals. However, it's important to monitor how these changes affect staff workload and patient care quality. The use of AI for predicting OR and PACU bed necessity, supply chain management and staff movement recommendations could lead to more efficient resource allocation, but may face resistance if not implemented with care for staff needs and preferences.

DENVER--(BUSINESS WIRE)-- Palantir Technologies Inc. (NYSE: PLTR) ("Palantir"), and Nebraska Medicine, a $2.5B academic health system based in Omaha, and a national leader in healthcare innovation, today announced a new multi-year, multi-million-dollar contract for Palantir’s Artificial Intelligence Platform (AIP) to help improve healthcare through transformational technologies.

Nebraska Medicine invests in driving innovation at a rate that most peers would deem impossible. Less than one year into the partnership, Nebraska Medicine has implemented more than ten applications of AIP, improving patient throughput, expanding claims reimbursements, and better monitoring patient care. AIP provides Nebraska Medicine safe and secure awareness of their operations, with long-term opportunities for transformation across Nebraska Medicine’s enterprise, and more.

Palantir and Nebraska Medicine started working together in January 2024, sharing a mission to rapidly solve critical healthcare problems. The proof: Nebraska Medicine represents Palantir’s fastest time to enterprise commitment of any Palantir health system partner to-date. In a series of targeted bootcamps, Nebraska Medicine took less than 6 weeks to put a new workflow in production and as little as 90 minutes to introduce more. Since partnering with Palantir, Nebraska Medicine has seen a +2000% increase in Discharge Lounge utilization, freeing up beds earlier for patients and decreasing time from discharge order to patient discharge by one hour on average. Furthermore, Nebraska Medicine sent 1,200+ AI-powered appeal letters to payors in less than 3 months, helping the health system more efficiently and effectively respond to claims denials, leveraging AI to combat payor behaviors. The areas of focus vary wider: Nebraska Medicine uses AIP to predict OR and PACU bed necessity, manage their supply chain, recommend staff movements, and more.

"Nebraska Medicine is one of the most innovative healthcare organizations in the country. While many organizations talk about having bold visions, Nebraska Medicine takes actions to translate ideas into real solutions, quickly," said Drew Goldstein, Co-Head of Healthcare at Palantir. "Their swift commitment to this enterprise partnership highlights our shared focus on rapidly delivering value and driving impactful outcomes to enhance patient care."

“Our partnership with Palantir is delivering real results for our patients and our staff,” said Michael Ash, MD, Nebraska Medicine president and chief operating officer. “The technology allows our staff to work smarter, and for more of our patients to leave the hospital as soon as they’re able. Most exciting for us – this is just the beginning of the innovations we’ll discover together and lead the way for other hospitals.”

Palantir will continue to work with Nebraska Medicine by providing AI software to help orchestrate patient flow, nurse allocation, clinical supplies management and revenue cycle optimization at scale, while expanding Nebraska’s Medicine core Foundry Ontology to additional high-priority areas through a single connected platform. Together, Palantir and Nebraska Medicine will explore novel opportunities in clinical research and clinical care to help improve patient outcomes.

Learn more about how Palantir is driving next-generation operations and outcomes for health systems.

About Palantir Technologies Inc.

Foundational software of tomorrow. Delivered today. Additional information is available at https://www.palantir.com.

About Nebraska Medicine

The Nebraska Medicine mission is to lead the world in transforming lives to create a healthy future for all individuals and communities through premier educational programs, innovative research and extraordinary patient care. More information is online at https://www.nebraskamed.com/.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements may relate to, but are not limited to, Palantir’s expectations regarding the amount and the terms of the contract and the expected benefits of our software platforms. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Forward-looking statements are based on information available at the time those statements are made and were based on current expectations as well as the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond our control. These risks and uncertainties include our ability to meet the unique needs of our customer; the failure of our platforms to satisfy our customer or perform as desired; the frequency or severity of any software and implementation errors; our platforms’ reliability; and our customer’s ability to modify or terminate the contract. Additional information regarding these and other risks and uncertainties is included in the filings we make with the Securities and Exchange Commission from time to time. Except as required by law, we do not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.

Lisa Gordon

media@palantir.com

Source: Palantir Technologies Inc.

FAQ

What is the financial value of the contract between Palantir (PLTR) and Nebraska Medicine?

The press release describes it as a multi-year, multi-million-dollar contract, but does not specify the exact financial value.

How has Palantir's AIP improved discharge processes at Nebraska Medicine?

Palantir's AIP has increased Discharge Lounge utilization by +2000% and decreased the time from discharge order to patient discharge by an average of one hour.

When did the partnership between Palantir (PLTR) and Nebraska Medicine begin?

The partnership between Palantir and Nebraska Medicine began in January 2024.

How many AI-powered appeal letters has Nebraska Medicine sent using Palantir's AIP?

Nebraska Medicine sent over 1,200 AI-powered appeal letters to payors in less than 3 months using Palantir's AIP.

Palantir Technologies Inc.

NYSE:PLTR

PLTR Rankings

PLTR Latest News

PLTR Stock Data

89.32B
2.14B
5.15%
42.48%
2.83%
Software - Infrastructure
Services-prepackaged Software
Link
United States of America
DENVER